ABOUT US

Since Ropack’s founding in 1976 as a two-person organization in 4,000 square feet of rented space to today’s global footprint, our goal has remained the same: to consistently deliver quality and reliability to our clients. Today we operate four state-of-the-art facilities in Montreal, Canada and offer pharmaceutical contract manufacturing and packaging services for all phases of the drug development process.  If you are looking for a strategic partner who stands ready to help you overcome the biggest challenges when bringing your drug to market, give us a call.

Because we have been true to our goal, Ropack Pharma Solutions counts among its client base many of the most-respected organizations in the pharmaceutical and nutraceutical industries

CONTRACT PACKAGING SERVICES

When Time-Reduction, Cost-Savings, Quality And Reliability Matter, Ropack Pharma Solutions Is The Distribution Partner Positioned To Deliver.

As your clinical material partner, we simplify – and accelerate – your clinical trials. From assistance with time-consuming international documentation through destruction following all regulatory protocols, RPS is your trusted clinical trial partner.

Ropack Pharma Solutions is positioned to warehouse and distribute even the most sensitive products.

Ropack Pharma Solutions provides a serialized supply chain that is proficient, verified and ready to safeguard your pharmaceutical product and the patients who depend on it.

Ropack Pharma Solutions is equipped to produce sachets in a range of fills, including powder, liquid/cream and solid dosage fill of one or two different products per sachet.

With ample available capacity, Ropack Pharma Solutions provides the efficiency of five bottling lines with quick changeovers, online validated fill accuracy and the flexibility to accommodate small lots to commercial runs for the bottling of tablets, capsules and powders.

The blending of APIs and excipients to create a homogenous blend is a crucial component in the solid dose and powder dose pharmaceutical manufacturing process. Because blender speed and time are key factors in achieving a uniform mixture, Ropack utilizes gold-standard technology.

Ropack Pharma Solution’s ample, nimble capacity and validated processes bring quality and reliability to encapsulation.

When time-reduction, cost-savings, quality and reliability matter, ropack pharma solutions is the distribution partner positioned to deliver.

The BEC 300, manufactured by Uhlmann, is the eighth and newest blister line at Ropack Pharma Solutions. The single-lane unit integrates blistering, cartoning and serialization. The highly efficient BEC 300, which produces cold formed (alu/alu) and Aclar® blisters at high speeds, will be serialization-ready by May 2017, well ahead of the Drug Supply Chain Security Act (DSCSA) mandate of November 2017.

Ropack Pharma Solutions offers a wide variety of clinical trial manufacturing services to the industry, by scientists with Big Pharma experience, utilizing gold-standard technology designed by the most-respected manufacturers in the pharmaceutical industry, such as Glatt and Korsch.

Ropack Pharma Solutions welcomes the challenge of solving complex supply issues by using a unique blend of traditional and innovative services that can significantly shorten timelines, reduce cost and improve drug availability and patient compliance.

Ropack Pharma Solutions offers turnkey primary and secondary pharmaceutical packaging services of solid oral dosages into blisters, bottles, flip-top vials, stick-packs and sachets.

Ropack provides a number of contract blister packaging services and can produce blister packaging in several different forms, including regular thermo-form, cold-formed, and heat-sealed blister cards.

CONTACT INFORMATION

Ropack Pharma Solutions

10801 Mirabeau St.

Montreal, QC H1J 1T7

CANADA

Phone: 514.353.7000 ext. 2272

Fax: 514-353-7211

Contact: Christopher Vounasis

FEATURED ARTICLES

  • In this Q&A we dig into some of the essential elements our experts identify as key to maintaining and enhancing both existing and new partnerships. Learn how outsourcing this key aspect of bringing product to market can benefit your organization and overall supply chain optimization.

  • Blister packaging, not long ago considered a less significant segment of the North American pharmaceutical packaging industry, is now outpacing most other industry segments. The pharmaceutical manufacturing industry has witnessed a significant increase in the number of drug approvals by the FDA over the past few years leading to several packaging innovations. Here are the factors that are driving blister to the forefront of pharmaceutical packaging, and at an even faster rate than its current growth.

  • As the COVID-19 pandemic continues, it is important to understand the expectations of regulators about how to facilitate paper-based facility inspections in lieu of those performed on site.

  • When asked about the biggest challenges to the pharmaceutical company sponsor-contract service provider relationship, sponsors and service providers offer pretty consistent responses.  

  • Determining a drug candidate’s probability of commercial success is a most significant phase in the drug development process. There is no room for error.

  • Using QRM gives a company the ability to maintain compliance while also identifying product issues that could be harmful to the consumers, some being susceptible patients.

  • As with the pharma industry, packagers are challenged to grow through innovation, by providing formats which satisfy pharma's expectation of enhanced drug integrity, safety, and stability while delivering the convenience demanded by today's consumer.

  • Quality metrics have been widely used in the pharma industry to monitor quality systems, operational processes, and to promote continuous improvement initiatives in drug manufacturing. 

  • A contract packaging partner should function as an extension of the pharma’s organization, so careful consideration should be devoted to initiating this relationship. 

  • Blister packaging, not long ago considered a less significant segment of the North American pharmaceutical packaging industry, is now outpacing most other industry segments. The pharmaceutical manufacturing industry has witnessed a significant increase in the number of drug approvals by the FDA over the past few years leading to several packaging innovations. Here are the factors that are driving blister to the forefront of pharmaceutical packaging, and at an even faster rate than its current growth.

  • Understanding the FDA audit process, preparing for it and being aware of regulations will help to restore a sense of control and help to ensure the best outcome.

  • Emerging countries offer a nearly untapped opportunity. Despite the opportunities, these markets also hold unique challenges. Blister packaging effectively addresses these challenges.

  • Trends in packaging of prescription and over-the-counter drugs indicate continued growth in the blister packaging market. 

VIDEOS

  • Ropack offers turnkey primary and secondary pharmaceutical packaging services of solid oral dosages, tablets, powder, and encapsulation into blisters, pouches, bottles, carded blisters and syringe assembly. Our facilities are cGMP compliant and FDA certified. Ropack is competitive, flexible and agile; supporting clinical trials, short run start-ups, commercial production and warehousing and distribution services for over 100 U.S., Canadian and European pharmaceutical and nutraceutical customers.

  • Ropack, Your Trusted Packaging Partner provides in-Canada clinical trial distribution reduces costs and shortens go-to-market timelines while ensuring accuracy and the highest level of security.

  • Ropack's in-Canada clinical trial distribution reduces costs and shortens go-to-market timelines while ensuring accuracy and the highest level of security. When pharmas and CROs send bulk product, Ropack purchases components in country and eliminates the governmental red tape and associated cost of shipping from out of country.